In this episode of MD Newsline, Dr. Diego Marzese, a breast cancer researcher specializing in epigenetics, explores how gene expression changes impact tumor behavior, treatment response, and disease progression. He discusses groundbreaking findings on how tumors activate or deactivate genetic alterations at different stages, the role of ethnicity in epigenetic variations, and how AI and machine learning are accelerating cancer research. Dr. Marzese also highlights the shift toward population-based health recommendations and the future of truly personalized cancer treatment.

Episode Highlights:

The Role of Epigenetics in Breast Cancer

Epigenetics refers to how environmental and lifestyle factors influence gene expression without altering DNA sequences. Dr. Marzese's research focuses on how tumors evolve over time, particularly in triple-negative breast cancer and ductal carcinoma in situ (DCIS). By identifying key epigenetic markers, researchers can predict which pre-cancerous conditions may progress to invasive cancer, enabling earlier and more precise treatment strategies.

Ethnicity and Tumor Behavior

Dr. Marzese's recent study found significant epigenetic differences across ethnic groups, particularly in young African American women with breast cancer. These patients exhibited unique hormone-related and muscle development pathway alterations, which may explain their poorer treatment response and higher disease aggressiveness. These findings emphasize the need for ethnicity-specific health recommendations and a more tailored approach to cancer prevention and treatment.

AI and the Future of Personalized Medicine

With the rise of AI and big data analysis, oncology research is progressing faster than ever. Scientists can now rapidly analyze entire genomes, identifying patient-specific treatment strategies that were once impossible. Dr. Marzese envisions a future where cancer treatment is no longer based on broad subtypes but tailored to each patient's unique genetic and epigenetic profile. However, he stresses that education for healthcare providers is crucial to integrating these advances into clinical practice.

Key Takeaway:

Epigenetics is reshaping breast cancer treatment by revealing how tumors evolve and respond to therapy. AI and personalized medicine are paving the way for patient-specific, ethnicity-informed treatment strategies.

Resources & Links:

Website: MD Newsline Newsletter: Subscribe Here